Page last updated: 2024-11-04

pyrithione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pyrithione: split from cephalosporin molecule; some metal complexes of this have fumarate reductase inhibitory activity and may be useful against trypanosomes; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pyrithione : A pyridinethione that is pyridine-2(1H)-thione in which the hydrogen attached to the nitrogen is replaced by a hydroxy group. It is a Zn(2+) ionophore; the zinc salt is used as an antifungal and antibacterial agent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1570
CHEMBL ID1650619
CHEMBL ID1356238
CHEBI ID36584
CHEBI ID36578
SCHEMBL ID49266
SCHEMBL ID24755
MeSH IDM0052791

Synonyms (104)

Synonym
HMS1772L20
1-oxido-2-pyridinyl hydrosulfide
pyridine-2-thiol n-oxide
pyridine-2-thiol 1-oxide
1-hydroxypyridine-2-thione
CHEBI:36584 ,
pyridine-2-thiol-1-oxide
1121-31-9
CHEBI:36578 ,
2-mercaptopyridine monoxide
1-hydroxyl-1h-pyridine-2-thione
1-hydroxypyridine-2(1h)-thione
unii-6gk82ec25d
6gk82ec25d ,
LS-13036
pyrithione
n-hydroxypyridine-2-thione
wln: t6nyj aq bus
nsc179790
sq 2113
2(1h)-pyridinethione, 1-hydroxy-
omadine
1-hydroxy-2(1h)-pyridinethione
nsc-179790
1-hydroxy-2-pyridinethione
1121-30-8
1-oxidopyridin-1-ium-2-thiol
2-thiopyridine-n-oxide-
brn 0906983
einecs 214-328-9
1-hydroxy-2-(1h)-pyridinethione
einecs 214-329-4
2-mercaptopyridine n-oxide
nsc 179790
ai3-60234
brn 0109936
2-pyridinethiol 1-oxide
2-hpt cpd
2-(1h)-pyridinethione, 1-hydroxy-
2-pyridinethiol, 1-oxide
2-mercaptopyridine-n-oxide
2-mercaptopyridine n-oxide, 99%
smr000814708
MLS001335993
MLS001335994 ,
inchi=1/c5h5nos/c7-6-4-2-1-3-5(6)8/h1-4,7h
ybbjkcmmcrqzma-uhfffaoysa-
BEW ,
H0302
AKOS001147723
A802495
1-oxidanylpyridine-2-thione
A802496
CHEMBL1650619
NCGC00246995-01
bdbm50366038
AKOS006239794
2(1h)-pyridinethione,1-hydroxy-
1-hydroxy-1h-pyridine-2-thione
5-21-07-00150 (beilstein handbook reference)
CHEMBL1356238 ,
FT-0612771
AB00615
2-pyridinethiol-1-oxide
pyrithione [mi]
pyridinethiol n-oxide
pyrithione [who-dd]
SCHEMBL49266
2-sulfanylpyridin-1-ium-1-olate
SCHEMBL24755
2-mercapto-pyridine-n-oxide
FGVVTMRZYROCTH-UHFFFAOYSA-N
mercapto pyridine-1-oxide
mercaptopyridine-1-oxide
2-mercaptopyridine-1-oxid
2-mercapto pyridine n-oxide
2-pyridinethiol-n-oxide
2-mercapto-pyridine-1-oxide
2mercapto pyridine n-oxide
YBBJKCMMCRQZMA-UHFFFAOYSA-N
2-mercaptopyridine 1-oxide
cid_1570
bdbm60985
W-108657
mfcd00006196
J-002710
BBL104003
DB06815
STL557814
DTXSID4048010
Q27116892
AS-10952
Q2119951
AM20210024
EN300-18970
SB21519
1-hydroxy-1,2-dihydropyridine-2-thione
HY-B1747
CS-0013767
D78428
A855797
DTXSID00149908 ,
2-ercaptopyridine--xide
dtxcid1072399

Research Excerpts

Overview

Pyrithione is a general inhibitor of membrane transport in fungi. It is widely used in antidandruff shampoos as an antifungal agent.

ExcerptReferenceRelevance
"Pyrithione is a general inhibitor of membrane transport in fungi and is widely used in antidandruff shampoos as an antifungal agent. "( Mechanism of pyrithione-induced membrane depolarization in Neurospora crassa.
Ermolayeva, E; Sanders, D, 1995
)
2.1

Dosage Studied

ExcerptRelevanceReference
" Motor neurons from both species exhibited dose-dependent NaP-evoked increases in [Ca(2+)](i) However, the dose-response curve for the Rhesus motor neurons was significantly shifted to the right of the rat dose-response curve, whereas the overall amplitude of the Ca(2+) rise was similar in both species."( Comparative effects of sodium pyrithione evoked intracellular calcium elevation in rodent and primate ventral horn motor neurons.
Barbee, SJ; Freyer, H; Kaczmarek, LK; Keen, KL; Knox, RJ; Luchansky, L; Terasawa, E, 2008
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
ionophoreA compound which can carry specific ions through membranes of cells or organelles.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pyridinethione
monohydroxypyridineA hydroxypyridine carrying a single hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (42)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency5.01190.044717.8581100.0000AID485294
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency3.54810.631035.7641100.0000AID504339
LuciferasePhotinus pyralis (common eastern firefly)Potency8.49210.007215.758889.3584AID588342
glp-1 receptor, partialHomo sapiens (human)Potency7.94330.01846.806014.1254AID624417
thioredoxin reductaseRattus norvegicus (Norway rat)Potency11.22020.100020.879379.4328AID588453
ClpPBacillus subtilisPotency3.98111.995322.673039.8107AID651965
ATAD5 protein, partialHomo sapiens (human)Potency15.16990.004110.890331.5287AID504466; AID504467
GLS proteinHomo sapiens (human)Potency22.38720.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency0.06960.000811.382244.6684AID686978; AID686979
Smad3Homo sapiens (human)Potency0.28180.00527.809829.0929AID588855
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency28.18380.707912.194339.8107AID720542
PINK1Homo sapiens (human)Potency2.81842.818418.895944.6684AID624263
hypothetical protein, conservedTrypanosoma bruceiPotency25.11890.223911.245135.4813AID624173
ParkinHomo sapiens (human)Potency2.81840.819914.830644.6684AID624263
IDH1Homo sapiens (human)Potency0.04110.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency1.12200.035520.977089.1251AID504332
beta-2 adrenergic receptorHomo sapiens (human)Potency0.73080.00586.026332.6427AID492947
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency22.38720.354828.065989.1251AID504847
chromobox protein homolog 1Homo sapiens (human)Potency3.54810.006026.168889.1251AID540317
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency20.59620.00419.984825.9290AID504444
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency89.12513.548119.542744.6684AID743266
flap endonuclease 1Homo sapiens (human)Potency89.12510.133725.412989.1251AID588795
ras-related protein Rab-9AHomo sapiens (human)Potency6.30960.00022.621531.4954AID485297
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency5.97280.168316.404067.0158AID720504
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency3.16230.050127.073689.1251AID588590
gemininHomo sapiens (human)Potency6.51310.004611.374133.4983AID624296
VprHuman immunodeficiency virus 1Potency4.46681.584919.626463.0957AID651644
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency12.58930.251215.843239.8107AID504327
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)Potency6.30960.058010.694926.6086AID602310
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 2Homo sapiens (human)Ki510.00000.00000.72369.9200AID1187448
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)0.05000.00022.45859.9600AID1640021
Lethal factorBacillus anthracisIC50 (µMol)5,000.00000.09702.85976.0000AID1187450
Protein-lysine 6-oxidaseHomo sapiens (human)IC50 (µMol)33.00000.01001.19705.0000AID1399349
Lysyl oxidase homolog 3Homo sapiens (human)IC50 (µMol)12.00000.09300.17080.3100AID1399351
Lysyl oxidase homolog 4Homo sapiens (human)IC50 (µMol)15.00000.05900.11950.1800AID1399352
Lysyl oxidase homolog 2Homo sapiens (human)IC50 (µMol)18.00000.06600.56494.2600AID1399350
large T antigenBetapolyomavirus macacaeIC50 (µMol)30.26000.160024.9724100.0000AID1903
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LAP4Saccharomyces cerevisiae (brewer's yeast)EC50 (µMol)8.92300.45008.371433.0000AID2745
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
FAD-linked sulfhydryl oxidase ALRHomo sapiens (human)AC500.43200.00503.212622.7870AID493248
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)AC501.00800.19503.667918.6960AID540270
twin arginine protein translocation system - TatA proteinEscherichia coli str. K-12 substr. MG1655AC509.47200.707010.915145.8560AID504941
heat shock protein 90, putativePlasmodium falciparum 3D7AC500.19500.19504.992098.5000AID540268
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (60)

Processvia Protein(s)Taxonomy
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
osteoblast differentiationProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of protein phosphorylationProtein-lysine 6-oxidaseHomo sapiens (human)
heart developmentProtein-lysine 6-oxidaseHomo sapiens (human)
response to xenobiotic stimulusProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of gene expressionProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of striated muscle tissue developmentProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of transforming growth factor beta receptor signaling pathwayProtein-lysine 6-oxidaseHomo sapiens (human)
peptidyl-lysine oxidationProtein-lysine 6-oxidaseHomo sapiens (human)
bone mineralizationProtein-lysine 6-oxidaseHomo sapiens (human)
lung developmentProtein-lysine 6-oxidaseHomo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayProtein-lysine 6-oxidaseHomo sapiens (human)
ascending aorta developmentProtein-lysine 6-oxidaseHomo sapiens (human)
descending aorta developmentProtein-lysine 6-oxidaseHomo sapiens (human)
protein modification processProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of apoptotic processProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of megakaryocyte differentiationProtein-lysine 6-oxidaseHomo sapiens (human)
muscle cell cellular homeostasisProtein-lysine 6-oxidaseHomo sapiens (human)
elastic fiber assemblyProtein-lysine 6-oxidaseHomo sapiens (human)
blood vessel morphogenesisProtein-lysine 6-oxidaseHomo sapiens (human)
response to steroid hormoneProtein-lysine 6-oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProtein-lysine 6-oxidaseHomo sapiens (human)
muscle cell developmentProtein-lysine 6-oxidaseHomo sapiens (human)
cell chemotaxisProtein-lysine 6-oxidaseHomo sapiens (human)
connective tissue developmentProtein-lysine 6-oxidaseHomo sapiens (human)
DNA biosynthetic processProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of bone developmentProtein-lysine 6-oxidaseHomo sapiens (human)
cellular response to chemokineProtein-lysine 6-oxidaseHomo sapiens (human)
regulation of platelet-derived growth factor receptor-beta signaling pathwayProtein-lysine 6-oxidaseHomo sapiens (human)
collagen fibril organizationProtein-lysine 6-oxidaseHomo sapiens (human)
epithelial to mesenchymal transitionLysyl oxidase homolog 3Homo sapiens (human)
inflammatory responseLysyl oxidase homolog 3Homo sapiens (human)
peptidyl-lysine oxidationLysyl oxidase homolog 3Homo sapiens (human)
spinal cord developmentLysyl oxidase homolog 3Homo sapiens (human)
lung developmentLysyl oxidase homolog 3Homo sapiens (human)
negative regulation of DNA-templated transcriptionLysyl oxidase homolog 3Homo sapiens (human)
roof of mouth developmentLysyl oxidase homolog 3Homo sapiens (human)
somite developmentLysyl oxidase homolog 3Homo sapiens (human)
fibronectin fibril organizationLysyl oxidase homolog 3Homo sapiens (human)
negative regulation of T-helper 17 cell lineage commitmentLysyl oxidase homolog 3Homo sapiens (human)
positive regulation of integrin-mediated signaling pathwayLysyl oxidase homolog 3Homo sapiens (human)
collagen fibril organizationLysyl oxidase homolog 3Homo sapiens (human)
collagen fibril organizationLysyl oxidase homolog 4Homo sapiens (human)
peptidyl-lysine oxidationLysyl oxidase homolog 4Homo sapiens (human)
negative regulation of transcription by RNA polymerase IILysyl oxidase homolog 2Homo sapiens (human)
response to hypoxiaLysyl oxidase homolog 2Homo sapiens (human)
epithelial to mesenchymal transitionLysyl oxidase homolog 2Homo sapiens (human)
endothelial cell proliferationLysyl oxidase homolog 2Homo sapiens (human)
sprouting angiogenesisLysyl oxidase homolog 2Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionLysyl oxidase homolog 2Homo sapiens (human)
peptidyl-lysine oxidationLysyl oxidase homolog 2Homo sapiens (human)
collagen fibril organizationLysyl oxidase homolog 2Homo sapiens (human)
positive regulation of chondrocyte differentiationLysyl oxidase homolog 2Homo sapiens (human)
protein modification processLysyl oxidase homolog 2Homo sapiens (human)
endothelial cell migrationLysyl oxidase homolog 2Homo sapiens (human)
negative regulation of DNA-templated transcriptionLysyl oxidase homolog 2Homo sapiens (human)
response to copper ionLysyl oxidase homolog 2Homo sapiens (human)
heterochromatin organizationLysyl oxidase homolog 2Homo sapiens (human)
negative regulation of stem cell population maintenanceLysyl oxidase homolog 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (23)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein-lysine 6-oxidase activityProtein-lysine 6-oxidaseHomo sapiens (human)
copper ion bindingProtein-lysine 6-oxidaseHomo sapiens (human)
protein bindingProtein-lysine 6-oxidaseHomo sapiens (human)
collagen bindingProtein-lysine 6-oxidaseHomo sapiens (human)
small molecule bindingProtein-lysine 6-oxidaseHomo sapiens (human)
molecular adaptor activityProtein-lysine 6-oxidaseHomo sapiens (human)
fibronectin bindingLysyl oxidase homolog 3Homo sapiens (human)
protein-lysine 6-oxidase activityLysyl oxidase homolog 3Homo sapiens (human)
copper ion bindingLysyl oxidase homolog 3Homo sapiens (human)
protein bindingLysyl oxidase homolog 3Homo sapiens (human)
protein-lysine 6-oxidase activityLysyl oxidase homolog 4Homo sapiens (human)
copper ion bindingLysyl oxidase homolog 4Homo sapiens (human)
protein bindingLysyl oxidase homolog 4Homo sapiens (human)
protein-lysine 6-oxidase activityLysyl oxidase homolog 2Homo sapiens (human)
copper ion bindingLysyl oxidase homolog 2Homo sapiens (human)
calcium ion bindingLysyl oxidase homolog 2Homo sapiens (human)
protein bindingLysyl oxidase homolog 2Homo sapiens (human)
oligosaccharide bindingLysyl oxidase homolog 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (18)

Processvia Protein(s)Taxonomy
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
extracellular regionProtein-lysine 6-oxidaseHomo sapiens (human)
extracellular spaceProtein-lysine 6-oxidaseHomo sapiens (human)
collagen trimerProtein-lysine 6-oxidaseHomo sapiens (human)
extracellular spaceProtein-lysine 6-oxidaseHomo sapiens (human)
collagen-containing extracellular matrixProtein-lysine 6-oxidaseHomo sapiens (human)
extracellular regionLysyl oxidase homolog 3Homo sapiens (human)
extracellular spaceLysyl oxidase homolog 3Homo sapiens (human)
nucleusLysyl oxidase homolog 3Homo sapiens (human)
cytoplasmLysyl oxidase homolog 3Homo sapiens (human)
membraneLysyl oxidase homolog 3Homo sapiens (human)
extracellular spaceLysyl oxidase homolog 3Homo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 3Homo sapiens (human)
membraneLysyl oxidase homolog 4Homo sapiens (human)
extracellular exosomeLysyl oxidase homolog 4Homo sapiens (human)
receptor complexLysyl oxidase homolog 4Homo sapiens (human)
extracellular spaceLysyl oxidase homolog 4Homo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 4Homo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 2Homo sapiens (human)
basement membraneLysyl oxidase homolog 2Homo sapiens (human)
extracellular spaceLysyl oxidase homolog 2Homo sapiens (human)
nucleusLysyl oxidase homolog 2Homo sapiens (human)
nucleoplasmLysyl oxidase homolog 2Homo sapiens (human)
endoplasmic reticulumLysyl oxidase homolog 2Homo sapiens (human)
membraneLysyl oxidase homolog 2Homo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 2Homo sapiens (human)
chromatinLysyl oxidase homolog 2Homo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 2Homo sapiens (human)
extracellular spaceLysyl oxidase homolog 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (34)

Assay IDTitleYearJournalArticle
AID1399349Inhibition of recombinant human LOX expressed in HEK293 cells using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID1399355Inhibition of recombinant human LOXL3 expressed in CHO cells at 10 uM using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method relative to control2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID1399351Inhibition of recombinant human LOXL3 expressed in CHO cells using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID1399356Inhibition of recombinant human LOXL4 expressed in baculovirus infected insect cells at 10 uM using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method relative to control2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID1399350Inhibition of recombinant LOXL2 (unknown origin) expressed in NS0 cells using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID1399352Inhibition of recombinant human LOXL4 expressed in baculovirus infected insect cells using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID1399353Inhibition of recombinant human LOX expressed in HEK293 cells at 10 uM using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method relative to control2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID1399354Inhibition of recombinant LOXL2 (unknown origin) expressed in NS0 cells at 10 uM using diaminopentane as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorimetric method relative to control2018Bioorganic & medicinal chemistry letters, 10-01, Volume: 28, Issue:18
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1187448Inhibition of human carbonic anhydrase using p-nitrophenylacetate as substrate preincubated for 10 mins before substrate addition by spectrophotometry2014Journal of medicinal chemistry, Aug-28, Volume: 57, Issue:16
Exploring the influence of the protein environment on metal-binding pharmacophores.
AID566704Inhibition of human recombinant MMP3 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566702Inhibition of human recombinant MMP1 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566706Inhibition of human recombinant MMP9 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566699Inhibition of mushroom tyrosinase at 1 mM after 10 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566703Inhibition of human recombinant MMP2 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566700Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1187450Binding affinity to anthrax lethal factor2014Journal of medicinal chemistry, Aug-28, Volume: 57, Issue:16
Exploring the influence of the protein environment on metal-binding pharmacophores.
AID1187449Binding affinity to Zn2+ in free solution2014Journal of medicinal chemistry, Aug-28, Volume: 57, Issue:16
Exploring the influence of the protein environment on metal-binding pharmacophores.
AID566705Inhibition of human recombinant MMP8 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566701Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (158)

TimeframeStudies, This Drug (%)All Drugs %
pre-199036 (22.78)18.7374
1990's27 (17.09)18.2507
2000's47 (29.75)29.6817
2010's38 (24.05)24.3611
2020's10 (6.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.43 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index139.99 (26.88)
Search Engine Supply Index3.84 (0.95)

This Compound (46.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.84%)5.53%
Reviews4 (2.45%)6.00%
Case Studies3 (1.84%)4.05%
Observational0 (0.00%)0.25%
Other153 (93.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]